Clinical Trial Results:
An 8-Week, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to
Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/day) as Adjunctive
Therapy in Adults With Major Depression Associated With
Bipolar I Disorder
Summary
|
|
EudraCT number |
2007-007555-14 |
Trial protocol |
HU BG |
Global completion date |
31 Dec 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
16 Nov 2016
|
First version publication date |
16 Nov 2016
|
Other versions |
|
Summary report(s) |
C10953-2032 SummaryResults.pdf |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.